0001062993-22-000242.txt : 20220104 0001062993-22-000242.hdr.sgml : 20220104 20220104162324 ACCESSION NUMBER: 0001062993-22-000242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAPLAN GILLA CENTRAL INDEX KEY: 0001247024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 22506343 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER NAME: FORMER CONFORMED NAME: KAPLAN GILLA PHD DATE OF NAME CHANGE: 20030625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-12-31 0001534120 Avalo Therapeutics, Inc. AVTX 0001247024 KAPLAN GILLA C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 0 0 0 Stock Option (Right to Buy) 1.70 2021-12-31 4 A 0 12767 0 A 2021-12-31 2031-12-31 Common Stock 12767 12767 D 100% of this stock option will immediately vest on the date that it is granted. /s/ Christopher R. Sullivan, by Power of Attorney 2022-01-04